Skip to main content
FinSpry Logo
FinSpry
SRZN logo
SRZN
(NASDAQ)
Surrozen, Inc.
$27.05-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Surrozen (SRZN) Stock Price & Financial Analysis

Surrozen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$26.88 - $28.72
52-Week High$35.00
52-Week Low$5.90
Open$28.12
Volume42.48K
Average Volume (3M)121.67K
Market Cap210.51M
Shares Outstanding7.48M
Price to Sales (P/S)60.54
Price to Book (P/B)-1.12
EV/EBITDA-3.39
Revenue (TTM)3.48M
Net Income (TTM)-242.03M
Free Cash Flow (TTM)-17.60M
EPS (TTM)$-34.31
Profit Margin-6960.77%
Operating Margin-1210.58%
50-Day MA$28.85
200-Day MA$19.47
52-Week Change266.00%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Surrozen

What is the current stock price for SRZN?

As of the latest trading session, SRZN stock trades at $27.44. The 52-week range is $5.90–$35.00, with a day range of $26.88–$28.72.

What is the P/E ratio for SRZN?

The P/E ratio (Price-to-Earnings) for SRZN is shown in the Key Statistics section. This valuation metric helps compare Surrozen, Inc. to industry peers.

Does SRZN pay dividends?

Surrozen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SRZN?

Based on 3 analysts, the consensus for SRZN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SRZN?

Surrozen's market capitalization is $205.2M, classifying it as a micro-cap company. Surrozen operates in the Healthcare sector within the Biotechnology industry.